You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK):Gland Pharma非正式招股書已遞交予SEBI、孟買證交所及印度證交所
格隆匯 11-03 18:19

格隆匯 11 月 3日丨復星國際(00656.HK)及復星醫藥(02196.HK)聯合宣佈,有關建議分拆GLAND PHARMA LIMITED並在孟買證券交易所及印度國家證券交易所獨立上市的進展。復星醫藥及復星國際接獲通知,於2020年10月31日,Gland Pharma已向印度的公司註冊處(位於印度特倫甘地的海德拉巴)遞交日期為2020年10月31日的非正式招股書。以電子形式遞交予公司註冊處的非正式招股書已在公司註冊處註冊。隨後,非正式招股書已於2020年11月2日遞交予SEBI、孟買證交所及印度證交所。非正式招股書可於孟買證交所(www.bseindia.com)、印度證交所(www.nseindia.com)、SEBI (www.sebi.gov.in)及與建議分拆及獨立上市相關的Gland Pharma有關賬簿管理牽頭經辦人網站瀏覽及下載。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account